Study Description Go to Brief Summary: This phase II trial studies how well atezolizumab works in treating patients with chondrosarcoma or clear cell sarcoma that is newly diagnosed, cannot be removed by surgery (unresectable), or has spread to…

Last Notice Chondrosarcoma CS Foundation, Inc. Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) This Event is Free to…

The Chondrosarcoma Foundation is hosting its first fundraising event to bring awareness to Chondrosarcoma: a rare bone and soft tissue cancer. Where: The comfort of your own neighborhood! When: anytime between October 3rd-9th …

https://www.eventbrite.com/e/steppin-for-a-cause-tickets-166736518415

The Chondrosarcoma CS Foundation, Inc. will host its Third International Forum / Virtual Dialogue featuring a panel of Chondrosarcoma Survivors and prominent experts to examine new technologies, medications, and clinical trials, as well as providing…

Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human Apo2L/TRAIL (Dulanermin), a Dual Proapoptotic Receptor (DR4/DR5) Agonist For more information: Targeting the Apoptotic Pathway in Chondrosarcoma Using Recombinant Human…

Did you know… Research initiated by the Bone Cancer Research Trust discovered that navigation guided surgery improves 5-year chondrosarcoma-specific survival from 53% to 76%! Read about this life-saving breakthrough and many more in our new…

Chondrosarcoma CS Foundation, Inc.Virtual Dialogue 3: Taking Charge of Your Care Third International Virtual Dialogue (VIA Zoom) Tuesday, September 14, 2021 7:30PM – 9:00PM (Eastern Standard Time / New York) Join Us for This Very Informative…